EFFICACY OF RITUXIMAB IN STEROID-SENSITIVE NEPHROTIC SYNDROME
Received: 2025-05-17
Published: 2025-05-03
Abstract
Steroid-sensitive nephrotic syndrome (SSNS) and steroid-resistant nephrotic syndrome (SRNS) have significant clinical importance for the quality of life in children. SSNS is characterized by frequent relapses, while SRNS carries a high risk of chronic progression and renal failure. Various immunosuppressive agents are used in treatment; however, in 10–20% of cases, they do not provide sufficient efficacy. In such cases, monoclonal antibody agents like rituximab (RTX) are required.
Keywords
List of references
About the Authors
How to Cite
EFFICACY OF RITUXIMAB IN STEROID-SENSITIVE NEPHROTIC SYNDROME. (2025). Herald of the National Children’s Medical Center, 110-112. https://hnchmc.uz/jour/article/view/164
